Cellular entry of the SARS coronavirus.
Hofmann
Heike
H
Institute for Clinical and Molecular Virology and Nikolaus-Fiebiger-Center, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Pöhlmann
Stefan
S
D000818:Animals; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism / Q000821:virology; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D011991:Receptors, Virus / Q000378:metabolism; D045473:Severe acute respiratory syndrome-related coronavirus / Q000378:metabolism* / Q000472:pathogenicity; D045169:Severe Acute Respiratory Syndrome / Q000276:immunology / Q000821:virology*; D064370:Spike Glycoprotein, Coronavirus; D014759:Viral Envelope Proteins / Q000378:metabolism*; D014765:Viral Vaccines / Q000494:pharmacology
D008562:Membrane Glycoproteins; D011991:Receptors, Virus; D064370:Spike Glycoprotein, Coronavirus; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C578557:spike glycoprotein, SARS-CoV; D007703:Peptidyl-Dipeptidase A